Table 1 The demographic data of patients included in study
From: suPARnostic: an advanced predictive tool for detecting recurrence in renal cell carcinoma
Number/Number (SD) | % | |
|---|---|---|
Age | 65.7 (SD 11.9) | |
BMI | 27.1(SD 5.9) | |
Ischemia time. min | 15.1(SD 13.3) | |
Operative time. min | 153.6 (SD 70.1) | |
Tumor size. mm | 55.4 (SD 33.4) | |
Gender | ||
Female | 84 | 35.7% |
Male | 151 | 64.3% |
T stage | ||
T1 | 161 | 68.5% |
T2 | 33 | 14.0% |
T3 | 41 | 17.4% |
Death | 56 | 23.8% |
Surgical techniques | ||
Partial nephrectomy | 84 | 35.7% |
Total nephrectomy | 151 | 64.3% |
Fuhrman grad | ||
1 | 32 | 13.6% |
2 | 87 | 37.0% |
3 | 43 | 18.3% |
4 | 13 | 5.6% |
Unkown | 60 | 25.5% |
Nicrosis | 53 | 22.6% |
Symptoms | 99 | 42.1% |
Hypertension | 84 | 35.7% |
Diabetes_mellitus | 35 | 14.9% |
Biopsies | 74 | 31.5% |
ASA score | ||
1 | 20 | 8.5% |
2 | 73 | 31.1% |
3 | 59 | 25.1% |
Unkonw | 83 | 35.3% |
Positive lymphnodes | 7 | 3.0% |
Smoking | ||
No | 99 | 42.3% |
Yes | 111 | 47.0% |
Pervious smokers | 25 | 10.7% |